Zacks Investment Research
01 Sept 2026, 15:46 UTC · 1h ago
NewsImpactScreener rates every claim in this story for market impact and maps it to the tickers most exposed.
Analysis by Kasper Rasmussen · Founder & analyst
What the story claims
4 claims · each scored for market impact
The Trump administration reclassified medical marijuana from a Schedule I to a Schedule III controlled substance in late April 2026. — This is a landmark federal policy shift that significantly reduces regulatory hurdles and unlocks growth potential for the cannabis industry.
+0.80U.S.-Iran tensions and cautions from Fed Chief Kevin Warsh have revived concerns regarding inflation and a potential interest rate hike in September. — Increased geopolitical risk and the prospect of higher interest rates typically dampen risk appetite and pressure equity valuations.
-0.60Palladium demand is projected to rise due to tighter emissions rules and hybrid-vehicle adoption, though supply risks persist in Russia and South Africa. — Stronger demand and constrained supply create a bullish fundamental environment for palladium prices.
+0.40Continue reading
6 related stories
Search tags
The S&P 500 has historically declined in September 56% of the time since 1927, with an average loss of 1.17%. — Seasonal trends can influence short-term investor sentiment and positioning, though they are less material than fundamental policy shifts.
-0.20Free · No account
Get a free daily PDF briefing — the last 24 hours of news, with summaries and the market-impact score for each story, delivered an hour before the open.
We’ll watch
Pre-filled from this story — remove any you don’t want. Add more tickers & tags or fine-tune your watchlist anytime — every email has an edit link, no account needed.
Free forever · one email a day, max · unsubscribe in one click.How it works
How the impact breaks down
Where the story's weight lands
Stocks most exposed
Modeled from each name's sensitivity to this story
No stock impact ranking available yet.
Kitco
4h ago
